(180) Multicenter analysis of outcomes in non-trial versus trial-like patients with commercial heartmate 3 LVAD

Authors

Laura Coyle, Advocate Aurora HealthFollow
Colleen Gallagher, Advocate Aurora HealthFollow
Nicole Graney, Advocate Aurora HealthFollow
Lisa Kukla, Advocate Aurora HealthFollow
Robin Paliga, Advocate Aurora HealthFollow
Kylie Hughes, Advocate Aurora HealthFollow
K Schultz, Advocate Aurora Health
Adam Schuldt, Advocate Aurora HealthFollow
Nasir Sulemanjee, Advocate Aurora HealthFollow
Anjali Joshi, Advocate Aurora HealthFollow
Gregory Macaluso, Advocate Aurora HealthFollow
Sunil Pauwaa, Advocate Aurora HealthFollow
Jessica Pillarella, Advocate Aurora HealthFollow
Christopher Sciamanna, Advocate Aurora HealthFollow
James Monaco, Advocate Aurora HealthFollow
Mohammad T. Kabbany, Advocate Aurora HealthFollow
William Cotts, Advocate Aurora HealthFollow
Nikhil Narang, Advocate Aurora HealthFollow
P Pappas, Advocate Aurora Health
Antone Tatooles, Advocate Aurora HealthFollow

Recommended Citation

Coyle L, Gallagher C, Graney N, et al. (180) Multicenter Analysis of Outcomes in Non-Trial versus Trial-Like Patients with Commercial Heartmate 3 LVAD. The Journal of heart and lung transplantation. 2023;42(4):S89. doi:10.1016/j.healun.2023.02.196

Affiliations

Advocate Christ Medical Center, Aurora St. Luke's Medical Center

Type

Abstract